🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
The purpose of this study is to investigate for the broad immunological eff...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT02710045
This is a phase IIb clinical trial investigating the non-inferiority of imm...
Status
Unknown
Location
Makarere University - Johns Hopkins University Collaboration
Start Date
2023-11-15
Trial ID
NCT06667206
Treatments Being Tested
The purpose of this study is to evaluate the immune response and safety of ...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-05-15
Trial ID
NCT06806137
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
To evaluate the safety and immunogenicity of GSK Biologicals' live attenuat...
Status
Completed
Location
Multiple Locations
Start Date
2000-11
Trial ID
NCT00388440
Treatments Being Tested
The purpose of this study is to determine the mumps virus strength at the e...
Status
Completed
Location
Multiple Locations
Start Date
1999-02
Trial ID
NCT00092391
The purpose of this study is to evaluate the safety, reactogenicity, and im...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2024-01-15
Trial ID
NCT06213506
The purpose of the primary phase of the study is to demonstrate the non-inf...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06-01
Trial ID
NCT00326118
The purpose of this study is to assess the immunogenicity, safety, and reac...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-05-10
Trial ID
NCT02699099
Treatments Being Tested